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Abstract—N,N-Bis-(tert-butoxycarbonyl)-2,5-bis-methoxycarbonyl-1,4-dihydropyrazine can be obtained in high yield by treatment of the
methyl ester of N-(4-toluenesulfonyl)-N-(tert-butoxycarbonyl)-a,b-didehydroalanine with dimethylaminopyridine and potassium carbonate.
This compound was used as substrate in Michael addition reactions with several types of nucleophiles. The electrochemical behaviour of this
pyrazine derivative was also studied by cyclic voltammetry and by controlled potential electrolysis.
q 2004 Published by Elsevier Ltd.1. Introduction
Diazines constitute an important class of heterocyclic
compounds present in several natural occurring compounds.
Pyrazines are found in the luminescent chromophores of
certain marine organisms,1 in cephalostatins isolated from
Cephalodiscus Gilchrist which are powerful anticancer
agents,2 in the fungal metabolite aspergillic acid3 and in
foods as potent flavour components.4 1,4-Dihydropyrazine
is an important structural unit of certain redox-active
biological molecules such as flavin coenzymes and several
marine luciferines.5 1,4-Dihydropyrazine derivatives also
constitute interesting electron donors in conducting charge
transfer complexes and magnetic materials. The properties
of 1,4-dihydropyrazines depend on the nature of the
substituents and on the planarity of the ring. When planar,
these ring systems can be considered ‘anti-aromatic’ due to
cyclic 8p-electron conjugation.5
Recently, we have demonstrated the versatility of the
methyl ester of N-(4-toluenesulfonyl)-N-(tert-butoxycar-
bonyl)-a,b-didehydroalanine [Tos-DAla(N-Boc)-OMe]6 as
a substrate in Michael addition reactions. This compound is
easily prepared in high yield from Tos-Ser-OMe by a di-
tert-butylpyrocarbonate/dimethylaminopyridine [(Boc)2O/
DMAP] mediated dehydration.6 Depending on the structure
of the nucleophile, several types of compounds can be
synthesized from Tos-DAla(N-Boc)-OMe, namely b-sub-
stituted alanine and dehydroalanine derivatives,7 furanic
amino acids, which by treatment with TFA yield dehydro-
proline derivatives8 and a,-substituted b-sufinylamino0040–4020/$ - see front matter q 2004 Published by Elsevier Ltd.
doi:10.1016/j.tet.2004.06.127
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the presence of DMAP undergoes a rearrangement to give
the E isomer of the methyl ester of N-(tert-butoxycarbonyl)-
O-(4-toluenesulfonyl)-a,b-didehydroserine.7 Here in, we
describe the synthesis and discuss the reactivity of N,N-bis-
(tert-butoxycarbonyl)-2,5-bis-methoxycarbonyl-1,4-di-
hydropyrazine obtained from Tos-DAla(N-Boc)-OMe.2. Results and discussion
When Tos-DAla(N-Boc)-OMe (compound 1) was reacted
with DMAP in acetonitrile in the presence of an excess of
potassium carbonate the product obtained was N,N-bis-(tert-
butoxycarbonyl)-2,5-bis-methoxycarbonyl-1,4-dihydro-
pyrazine in 89% yield (compound 2, Scheme 1). By
sampling the reaction mixture and carrying out 1H NMR
analysis, it was found that the reaction proceeds via the
formation of the methyl ester of N-(tert-butoxycarbonyl)-O-
(4-toluenesulfinyl)-a,b-didehydroserine. Alternatively,
compound 2 can be prepared in a one pot procedure
from Tos-Ser-OMe by reacting with (Boc)2O and
DMAP (0.1 equiv) in dry acetonitrile for 30 min and then
adding K2CO3 (6 equiv) and more DMAP (1 equiv) (78%
yield).
The presence of electron withdrawing substituents on 1,4-
dihydropyrazine systems has a stabilizing effect thus
allowing the preparation and isolation of such compounds.5b
In the case of compound 2 the stabilizing effect of the ester
groups is reinforced by the presence of the Boc groups on
the nitrogen atoms. These groups are essential for
stabilization of this 1,4-dihydropyrazine system since
treatment of compound 2 with TFA gave 2,5-bis-methox-
ycarbonylpyrazine in 71% yield (compound 3, Scheme 2).
The methoxycarbonyl substituents in compound 3 cause theTetrahedron 60 (2004) 8489–8496
Scheme 1.
Scheme 2.
A. Rodrigues et al. / Tetrahedron 60 (2004) 8489–84968490aromatic protons to show a downfield shift in the 1HNMR
spectrum (9.42 ppm in CDCl3) when compared with those
of unsubstituted pyrazine (8.60 ppm in CDCl3).
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The four electron-withdrawing groups of compound 2made
it possible to use this compound as an electrophile in
Michael addition reactions. Thus, compound 2 was treated
with several types of nucleophiles namely: 1,2,4-triazole,
3-formylindole, benzylamine, 4-bromothiophenol and
sodium methoxide to give one of the diasteriomers of the
corresponding 3-substituted-2,5-bis-methoxycarbonyl-
1,2,3,4-tetrahydropyrazine derivatives in good to high
yields (compounds 4a-e, Scheme 2). 1H NMR spectra ofthese addition products at 25 8C in CDCl3 showed 4a-e to be
rotameric mixtures with no coupling between the 2-H and
3-H protons which indicate that the diastereomer obtained
corresponds to the trans isomer. 1H NMR analysis of the
Michael adducts show that the remaining vinylic proton
suffers from a downfield shift (from 7.09 ppm to values
ranging from 7.24 to 7.78 ppm). This has been found in
other cases in which cyclic 8p-electron conjugated systems
are reduced to non-aromatic compounds.5b,10 Treatment of
compounds 4c and 4d with TFA resulted in cleavage of the
Boc groups and elimination of the nucleophile giving the
pyrazine derivative 3 (76 and 74%, respectively). This
indicates that the presence of electron withdrawing
A. Rodrigues et al. / Tetrahedron 60 (2004) 8489–8496 8491substituents on the nitrogen atoms is also essential for
stabilization of these non-aromatic tetrahydropyrazine
systems.
The UV spectrum of compound 2 shows two absorption
bands at 225 and 276 nm (extinction coefficients of 43,265Figure 1. UV spectra of compounds 2 and 3 in dichloromethane.and 31,720 MK1 cmK1) and is similar to the UV spectrum
of compound 3 which shows absorption bands at the same
wavelengths (extinction coefficients of 34,615 and
23,330 MK1 cmK1) (Fig. 1).
Cyclic voltammetry of compound 2 between K1.0 and
A. Rodrigues et al. / Tetrahedron 60 (2004) 8489–849684921.8 V showed a single oxidation peak at 1.20 V versus SCE
(Fig. 2). The oxidation potential described for N-ethyl-1,4-
dihydropyrazine is K0.67 V versus SCE.11 Thus, the high
potentials for oxidation of compound 2 can be assigned to
the electron-withdrawing effect of the substituents which
makes the loss of electrons more difficult. A potential sweepFigure 2. Cyclic voltammograms at a vitreous carbon electrode of a 0.005 mol
supporting electrolyte at a sweep rate of 100 mV sK1 (SCEZstandard calomel efrom 0 to K2.8 V showed a reduction peak at K2.14 V
versus SCE (Fig. 2).
The pyrazine derivative (compound 3) shows no oxidation
peak in the range between K1.0 and 1.8 V. A potential
sweep from 0 to K2.8 V showed two reduction peaks atdmK3 solution of compound 2 in DMF with 0.1 mol dmK3 Bu4NBF4 as
lectrode).
Figure 3. Cyclic voltammogram at a vitreous carbon electrode of a 0.005 mol dmK3 solution of compound 3 in DMF with 0.1 mol dmK3 Bu4NBF4 as
supporting electrolyte at a sweep rate of 100 mV K1 (SCEZstandard calomel electrode).
A. Rodrigues et al. / Tetrahedron 60 (2004) 8489–8496 8493K1.00 and K1.82 V versus SCE (Fig. 3). Considering the
electron-withdrawing effect of the substituents, the first
reduction potential for 2,5-bis-methoxycarbonylpyrazine is
in agreement with that found for: unsubstituted pyrazine
(K2.16 versus SCE);12 2-carboxamide pyrazine (K1.75 V
versus SCE);13 and with the first reduction peak of
chloropyrazine (K1.78 V versus SCE).12
In view of the cyclic voltammetry data obtained, controlled
potential electrolysis of compound 2 at the oxidation and
reduction peak potentials were carried out. In these
reactions tetraethylammonium chloride was used as sup-
porting electrolyte and triethylammonium chloride as
electron donor. Oxidation of compound 2 gave one of the
diastereomers of N,N-bis-(tert-butoxycarbonyl)-2,3-
dichloro-2,5-bis-methoxycarbonyl-1,2,3,4-tetrahydropyra-
zine (compound 5) in 91% yield (Scheme 3). The formation
of this compound can be due to oxidation to give a radical
cation which reacts with the chloride ions present in
solution. Reduction of compound 2 gave as expected N,N-
bis-(tert-butoxycarbonyl)-2,5-bis-methoxycarbonyl-Scheme 3.1,2,3,4-tetrahydropyrazine (compound 6) in 55% yield
(Scheme 3).3. Conclusion
The common method for the synthesis of pyrazines involves
the cyclocondensation of nitrogen nucleophiles onto
a-dicarbonyl systems. We developed a new high yielding
method for the synthesis of a 1,4-dihydropyrazine derivative
from the methyl ester of N-(4-toluenesulfonyl)-N-(tert-
butoxycarbonyl)-a,b-didehydroalanine by treatment with
DMAP and K2CO3. This compound was easily converted
into 2,5-bis-carboxymethylpyrazine by treatment with TFA.
The 1,4-dihydropyrazine derivative is also a good substrate
for the diastereoselective synthesis of several tetrahydro-
pyrazines, in good to high yields, either by Michael addition
reactions or by controlled potential electrolysis. Several of
these diazine derivatives can have biological activity since
pyrazinamide is one of the front line agents against
M. Tuberculosis,14 some dihydropyrazines such as
A. Rodrigues et al. / Tetrahedron 60 (2004) 8489–849684942,3-dihydro-5,6-dimethylpyrazine showed DNA strand-
breaking activity in plasmid15 and tetrahydropyrazines
have been used in the synthesis of a HIV protease
inhibitor.164. Experimental
4.1. Materials and methods
Melting points were determined in a Gallenkamp apparatus
and are uncorrected. 1H and 13C NMR spectra were
recorded on a Varian Unity Plus at 300 and 75.4 MHz,
respectively. 1H–1H spin–spin decoupling and DEPT q 458
were used. Chemical shifts are given in ppm and coupling
constants in Hz. MS and HRMS data were recorded by the
mass spectrometry service of the University of Vigo, Spain.
Elemental analysis was performed on a LECO CHNS 932
elemental analyser.
The reactions were monitored by thin layer chromatography
(TLC). Column chromatography was performed on
Macherey–Nagel silica gel 230–400 mesh. Petroleum
ether refers to the boiling range 40–60 8C.
4.1.1. Synthesis of Tos-DAla(N-Boc)-OMe. The synthesis
of these compounds was described in Ref. 6.
4.1.2. Synthesis of N,N-bis-(tert-butoxycarbonyl)-2,5-bis-
methoxycarbonyl-1,4-dihydropyrazine (2) from Tos-
DAla(N-Boc)-OMe. To a solution of Tos-DAla(N-Boc)-
OMe in acetonitrile (0.1 mol dmK3), K2CO3 (6 equiv) was
added, followed by 1 equiv of DMAP, with fast stirring at
room temperature. The reaction was monitored by TLC,
(diethyl ether/n-hexane, 1:1) and when no starting material
nor Boc-DSer(O-toluenesulfinyl)-OMe was detected
(z72 h), the solution was filtered and evaporated at reduced
pressure (the same procedure but heating the reaction
mixture under reflux allowed the reaction to be complete in
12 h). The residue obtained was partitioned between
200 cm3 of diethyl ether and 100 cm3 of KHSO4
(1 mol dmK3). The organic phase was thoroughly washed
with KHSO4 (1 mol dm
K3), NaHCO3 (1 mol dm
K3) and
brine (3!50 cm3 each), and dried over MgSO4. Removal of
the solvent afforded pure compound 2 (89%), mp 155.0–
156.0 8C (from diethyl ether/n-hexane). 1H NMR (CDCl3):
1.50 (18H, s, CH3 2Boc), 3.80 (6H, s, 2CH3 OMe), 7.09
(2H, s, 3-HC6-H); 13C NMR (CDCl3): 27.88, 52.27, 83.65,
119.82, 127.68, 148.82, 162.58; MS: m/z (%)Z399 (14)
[MCC1], 398 (20) [MC], 343 (36) [MCKCO2Me], 298 (6)
[MCKBoc], 198 (100) [MCK2Boc]. Anal. Calcd for
C18H26N2O8 (398.41): C 54.27; H 6.58; N 7.03; found C
54.42; H 6.72; N 6.94.
4.1.3. Synthesis of N,N-bis-(tert-butoxycarbonyl)-2,5-bis-
methoxycarbonyl-1,4-dihydropyrazine (2) from Tos-
Ser-OMe. To a solution of Tos-Ser-OMe in dry acetonitrile
(0.1 mol dmK3), 0.1 equiv of DMAP were added, followed
by Boc2O (2.2 equiv) with fast stirring at room temperature.
After reacting for 30 min more DMAP (1 equiv) was added
and also K2CO3 (6 equiv). After reacting for approximately
3 days the same work-up as described above was carried out
to give compound 2 (78% yield).4.1.4. Synthesis of 2,5-bis-methoxycarbonylpyrazine (3).
To a solution of compound 2 in dichloromethane
(0.02 mol dmK3), 10% trifluoroacetic acid was added with
fast stirring at room temperature. The reaction was
monitored by TLC, (diethyl ether/n-hexane, 1:1) and when
no starting material was detected removal of the solvent
afforded pure compound 3 (71%), mp 145.5–147.0 8C (from
diethyl ether/n-hexane). 1H NMR (CDCl3): 4.10 (6H, s,
2CH3 OMe), 9.42 (2H, s, 3-HC6-H);
13C NMR (CDCl3):
53.55, 145.18, 145.52, 163.52. Anal. Calcd for C8H8N2O4
(196.16): C 48.98; H 4.11; N 14.28; found C 49.06; H 4.10;
N 14.00.
4.1.5. Synthesis of N,N-bis-(tert-butoxycarbonyl)-2,5-bis-
methoxycarbonyl-3-(triazol-1-yl)-1,2,3,4-tetrahydro-
pyrazine (4a). To a solution of compound 2 in acetonitrile
(0.1 mol dmK3), K2CO3 (6 equiv) was added, followed by
1 equiv of 1,2,4-triazole, with fast stirring at room
temperature. The reaction was monitored by TLC, (diethyl
ether/n-hexane, 1:1) and when no starting material was
detected (z16 h), the solution was filtered and evaporated
under reduced pressure. The residue obtained was par-
titioned between 100 cm3 of diethyl ether and 30 cm3 of
NaHCO3 (1 mol dm
K3). The organic phase was washed
with NaHCO3 (1 mol dm
K3) and brine (2!30 cm3 each),
and dried over MgSO4. Removal of the solvent afforded
compound 4a as an enantiomeric mixture of the trans
diastereomer (92%); oil; 1H NMR (CDCl3) (2 rotamers):
1.48, 1.50 (36H, 2s, CH3 Boc), 3.79, 3.81 (12H, 2s, CH3
OMe), 5.93, 6.03, 6.93, 6.99 (4H, 4s, 2-HC3-H pyr.), 7.36,
7.57 (2H, 2s, 6-H pyr.), 7.92 (2H, s, 3-H or 5-H triaz.), 8.32
(2H, s, 3-H or 5-H triaz.); 13C NMR (CDCl3): 27.69, 27.83,
52.15, 53.12, 56.26, 57.40, 63.20, 83.79, 84.37, 122.46,
127.64, 148.50, 150.04, 152.26, 166.72; MS: m/z (%)Z467
(7) [MC], 367 (3) [MCKBoc], 267 (24) [MCK2Boc], 198
(100) [MCK2Boc-triaz.]; HRMS found 467.2016, Calcd
for C20H29N5O8 467.2016.
4.1.6. Synthesis of N,N-bis-(tert-butoxycarbonyl)-2,5-bis-
methoxycarbonyl-3-(3-formylindol-1-yl)-1,2,3,4-tetra-
hydropyrazine (4b). The same procedure described for the
synthesis of compound 4a was applied substituting
3-formylindole for 1,2,4-triazole. Removal of the solvent
afforded compound 4b as an enantiomeric mixture of the
trans diastereomer (90%), mp 156.0–157.0 8C (from ethyl
acetate/n-hexane). 1H NMR (CDCl3) (2 rotamers): 1.48,
1.54 (36H, 2s, CH3 Boc), 3.75, 3.84 (12H, 2s, CH3 OMe),
5.40, 5.56 (2H, 2s, 2-H or 3-H pyr.), 7.23–7.58 (10H, m, 2-H
or 3-HC6-H pyr.C2-HC5-HC6-H ind.), 7.73 (2H, d, JZ
7.5 Hz, 7-H ind.), 8.31 (2H, d, JZ7.8 Hz, 4-H ind.), 9.95
(2H, s, CHO); 13C NMR (CDCl3): 27.73, 27.92, 52.12,
53.39, 57.01, 59.95, 83.76, 85.32, 110.33, 110.65, 119.27,
121.69, 122.13, 123.67, 124.84, 125.13, 134.17, 136.60,
150.41, 151.83, 163.91, 166.70, 184.94. Anal. Calcd for
C27H33N3O9 (543.57): C 59.66; H 6.12; N 7.73; found C
59.87; H 6.18; N 7.78.
4.1.7. Synthesis of N,N-bis-(tert-butoxycarbonyl)-2,5-bis-
methoxycarbonyl-3-(4-bromophenylsulfanyl)-1,2,3,4-
tetrahydropyrazine (4c). The same procedure described
for the synthesis of compound 4a was applied substituting
4-bromothiophenol for 1,2,4-triazole. Removal of the
solvent afforded compound 4c as an enantiomeric mixture
A. Rodrigues et al. / Tetrahedron 60 (2004) 8489–8496 8495of the trans diastereomer (76%), mp 137.0–138.5 8C (from
diethyl ether/n-hexane). 1H NMR (CDCl3) (2 rotamers):
1.34, 1.49, 1.57 (36H, 3s, CH3 Boc), 3.69, 3.78 (12H, 2s,
CH3 OMe), 4.89, 5.08 (2H, 2s, 2-H or 3-H), 6.15, 6.21 (2H,
2s, 2-H or 3-H), 7.48 (8H, broad s, ArH), 7.56, 7.78 (2H, 2s,
6-H); 13C NMR (CDCl3): 27.66, 28.00, 51.83, 52.87, 57.30,
57.60, 58.23, 59.77, 82.41, 84.29, 108,52, 122.44, 130.50,
132.04, 135.32, 150.67, 151.22, 164.26, 167.27. Anal. Calcd
for C24H31N2O8SBr (587.48): C 49.07; H 5.32; N 4.77; S
5.46; found C 49.40; H 5.52; N 4.81; S 5.40.
4.1.8. Synthesis of N,N-bis-(tert-butoxycarbonyl)-2,5-bis-
methoxycarbonyl-3-(benzylamino)-1,2,3,4-tetrahydro-
pyrazine (4d). The same procedure described for the
synthesis of compound 4a was applied substituting
benzylamine for 1,2,4-triazole. Removal of the solvent
afforded compound 4d as an enantiomeric mixture of the
trans diastereomer (82%), mp 106.5–107.5 8C (from diethyl
ether/n-hexane). 1H NMR (CDCl3) (2 rotamers): 1.42, 1.45,
1.52 (36H, 3s, CH3 Boc), 3.70 (6H, s, CH3 OMe), 3.80–3.92
(10H, m, CH3 OMeCCH2 Bn), 4.82, 4.97 (2H, 2s, 2-H or
3-H), 5.60, 5.65 (2H, 2s, 2-H or 3-H), 7.28–7.36 (10H, m,
ArH), 7.50, 7.71 (2H, 2s, 6-H); 13C NMR (CDCl3): 27.87,
27.97, 49.47, 51.77, 52.57, 59.27, 60.55, 62.41, 81.58,
84.02, 121.51, 127.25, 128.43, 128.56, 139.17, 150.69,
152.75, 164.99, 167.85, 168.07. Anal. Calcd for
C25H35N3O8 (505.56): C 59.39; H 6.98; N 8.31; found C
59.43; H 7.21; N 8.05.
4.1.9. Synthesis of N,N-bis-(tert-butoxycarbonyl)-2,5-bis-
methoxycarbonyl-3-methoxy-1,2,3,4-tetrahydropyra-
zine (4e). The same procedure described for the synthesis of
compound 4a was applied substituting sodium methoxide
for 1,2,4-triazole. Removal of the solvent afforded com-
pound 4e as an enantiomeric mixture of the trans
diastereomer (35%); oil; 1H NMR (CDCl3) (2 rotamers):
1.43, 1.47, 1.53 (36H, 3s, CH3 Boc), 3.40 (6H, s, CH3
COMe), 3.70, 3.79 (12H, 2s, CH3 COOMe), 4.89, 5.05 (2H,
2s, 2-H or 3-H), 5.79, 5.84 (2H, 2s, 2-H or 3-H), 7.51, 7.72
(2H, 2s, 6-H), 13C NMR (CDCl3): 27.85, 28.01, 51.77,
52.70, 55.26, 58.78, 60.18, 77.96, 82.02, 83.56, 83.91,
107.85, 122.47, 150.81, 167.37; MS: m/z (%)Z430 (8)
[MC], 230 (100) [MCK2Boc], 199 (21) [MCK2Boc-
OMe]; HRMS found 430.1947, Calcd for C19H30N2O9
430.1951.
4.1.10. Synthesis of N,N-bis-(tert-butoxycarbonyl)-2,3-
dichloro-2,5-bis-methoxycarbonyl-1,2,3,4-tetrahydro-
pyrazine (5). A solution of Et4NCl (0.1 mol dm
K3;
supporting electrolyte) and Et3NHCl (0.04 mol dm
K3;
proton donor) in MeCN was added to a two compartment,
three-electrode cell. Compound 2 (99.5 mg, 0.25 mmol)
was added to the anodic compartment and a cyclic
voltammogram recorded. The potential was adjusted to a
value 50 mV more positive than that corresponding to the
CV peak and the electrolysis started, the reaction being
monitored by HPLC. When all starting material had
disappeared, the content of the anodic compartment was
concentrated under reduced pressure and the residue
partitioned between 100 cm3 of ethyl acetate and 50 cm3
of water. The organic phase was then washed with water and
brine (3!30 cm3 each) and dried over MgSO4. The solution
was filtered and the solvent removed to give a residue whichwas submitted to column chromatography using diethyl
ether/n-hexane (1:2) as eluent to give compound 5
(106.8 mg, 91%), mp 119.5–121.0 8C (from diethyl ether/
n-hexane). 1H NMR (CDCl3): 1.49, 1.53 (18H, 2s, CH3
Boc), 3.82, 3.88 (6H, 2s, CH3 OMe), 6.61 (1H, s, 3-H), 7.56
(1H, s, 6-H); 13C NMR (CDCl3): 27.70, 27.76, 52.24, 54.24,
68,71, 83.93, 85.91, 109.74, 122.00, 126.15, 148.79,
149.05, 163.20, 163.68; MS: m/z (%)Z470 (1) [MCC2],
468 (1.3) [MC], 368 (2) [MCKBoc], 268 (57) [MCK
2Boc], 233 (63) [MCK2Boc-Cl], 197 (100) [MCK2Boc-
2Cl]. HRMS found 468.1082, Calcd for C18H26N2O8Cl2
468.1066.
4.1.11. Synthesis of N,N-bis-(tert-butoxycarbonyl)-2,5-
bis-methoxycarbonyl-1,2,3,4-tetrahydropyrazine (6).
The same procedure as described above was followed but
adding compound 2 (99.5 mg, 0.25 mmol) to the cathodic
compartment to give compound 6 (55.2 mg, 55.2%). 1H
NMR (CDCl3): 1.41, 1.52 (18H, 2s, CH3 Boc), 2.96–3.08
(1H, m, 3-H), 3.71, 3.78 (6H, s, 2CH3 OMe), 4.68–4.90 (2H,
m, 2-HC3-H), 7.53 (1H, s, 6-H); 13C NMR (CDCl3): 27.82,
27.88, 42.27, 51.75, 52.62, 54.70, 55.98, 81.69, 83.58,
83.90, 109.60, 123.01, 150.52, 150.64, 169.00, 169.35;
MS: m/z (%)Z400 (4) [MC], 200 (100) [MCK2Boc],
167 (11) [MCK2Boc-OMe], 141 (13) [MCK2Boc-
CO2Me]; HRMS found 400.1857, Calcd for C18H28N2O8
400.1846.Acknowledgements
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